Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Bronchoscopy & lung nodule · Pennsylvania | Bronchoscopy & lung nodule · New York | |
|---|---|---|
| Surgeons, 2024 | 75 | 82 |
| Medicare fee-for-service cases | 5,343 | 4,973 |
| Growth since 2019 (Medicare FFS) | +1.2%/yr | +1.9%/yr |
| Forecast cases (Medicare FFS) | 7,380 in 2030 | 7,320 in 2030 |
| Forecast growth | +5.5%/yr to 2030 | +6.6%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 4.0 | 2.8 |
| Medicare Advantage share | 58% | 57% |
| Out of hospital | 0% (+0 pts since 2019) | 0% (−0 pts since 2019) |
| Cases per surgeon | 71 | 61 |
| Top 10 surgeons' share | 41% | 36% |
| Surgeons growing | 14 | 12 |
| New since the base year | 21 | 16 |
| Likely to stop billing it | 15 by 2026 | 17 by 2026 |
| Forecast miss, 1 year (procedure) | 6% | 6% |
| Company payments per surgeon | $4,953 | $5,287 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.